Pharmacy benefit managers (PBMs) in the United States have come under scrutiny in recent years due to various reasons. PBMs are third-party administrators that work with health insurance companies to manage prescription drug programs. While they were initially intended to help control costs and improve efficiency in the healthcare system, they have faced criticism for their practices.
One of the main reasons PBMs are under fire is their role in drug pricing. Critics argue that PBMs contribute to the rising costs of prescription drugs by negotiating rebates and discounts with drug manufacturers and pharmacies, but often do not pass these savings on to consumers. This lack of transparency in pricing has led to concerns about the affordability of medications for patients.
